Global Cancer Diagnostics, Inc. Email Format

BiotechnologyArizona, United States0-1 Employees

Global Cancer Diagnostics, Inc. is a biotechnology research company based in Tempe, Arizona. The firm focuses on developing diagnostic tools for cancer risk assessment, most notably offering the Lung Cancer Test, a blood-based assay intended to determine the risk of lung cancer in early stages within a high-risk population of smokers and former smokers over age 50. The test is priced affordably at $99 plus shipping and handling, and the company launched the product publicly in October 2014. Positioned within the biotechnology research industry, the company concentrates on advancing screening options that could enable earlier detection in individuals at elevated risk, with the goal of informing clinical decisions and potentially improving outcomes. The organization appears to operate with a lean structure, reflecting limited stated personnel, and it maintains its online presence at the provided website.

Get verified Global Cancer Diagnostics, Inc. emails free

Company overview Employee directory